IRCCS Policlinico San Donato

Running trials

• Not yet recruiting

  Validation Of anatomY-specific Aortic Valve Implantation Guided by Software Using EncantoR

  NCT07696182· Abbott Medical Devices· Source

• Not yet recruiting

  A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events

  NCT07474649· Phase 3· Daiichi Sankyo· Source

• Recruiting

  OPTION-EMEA Clinical Trial

  NCT07349121· Boston Scientific Corporation· Source

• Active, not recruiting

  A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE PRO Software in Participants With PsAF

  NCT07428564· Biosense Webster, Inc.· Source

• Recruiting

  Pharmacological Optimization in Prevention in Heart Failure: A Sex-gap?

  NCT07295522· Phase 4· IRCCS Policlinico S. Donato· Source

• Recruiting

  LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

  NCT07415044· Phase 2· Eli Lilly and Company· Source

• Active, not recruiting

  A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE Pro Software in Participants With PAF or PsAF

  NCT07429214· Biosense Webster, Inc.· Source

• Recruiting

  Poland-Italy Aortic Research Bridge Real World Registry

  NCT07476196· American Heart of Poland· Source

• Recruiting

  Lombard Cohort of Brain Health Services

  NCT07457138· University of Milano Bicocca· Source

• Not yet recruiting

  Analysis of the Presence and Cardiac Functional Effects of Anti-NaV1.5 Autoantibodies in Patients With Metastatic Tumors

  NCT07364656· IRCCS Policlinico S. Donato· Source

• Recruiting

  A Research Study to Look at the Effect of Ziltivekimab on Plaque in the Blood Vessels of the Heart, Compared to Placebo, in People With a Heart Attack

  NCT07301034· Phase 3· Novo Nordisk A/S· Source

• Enrolling by invitation

  Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria

  NCT07256392· Phase 3· Celldex Therapeutics· Source

• Recruiting

  Strength Tracking From Wall Tichness Over Aortic Biomechanics (STORM)

  NCT07453251· IRCCS Policlinico S. Donato· Source

• Recruiting

  Phenotyping Left Ventricle Failure With Hemodynamic Biomarkers From 4D Flow Magnetic Resonance Imaging

  NCT07455292· IRCCS Policlinico S. Donato· Source

• Recruiting

  International Multicenter Study of the Navitor/Navitor Vision Transcatheter Aortic Valve Platform

  NCT07359898· IRCCS Policlinico S. Donato· Source

• Recruiting

  The Signature of Alzheimer's Disease in Subjective Cognitive Decline

  NCT07402161· IRCCS Policlinico S. Donato· Source

• Recruiting

  Surgical vs Transcatheter Aortic Valve Replacement in YOUNG Patients

  NCT06861361· Ceric Sàrl· Source

• Recruiting

  Genetic Aortic Diseases and Cardiovascular Complications. An Observational Survey of Risk Factors.

  NCT07391293· IRCCS Policlinico S. Donato· Source

• Recruiting

  Functional Capacity in Anderson-Fabry Disease Patients

  NCT06884358· IRCCS Policlinico S. Donato· Source

• Active, not recruiting

  A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

  NCT06598943· Phase 2· Eli Lilly and Company· Source

• Recruiting

  Speed-up the Diagnosis and Evaluation of anoMalous Coronary ARTery From the Aorta

  NCT06705751· IRCCS Policlinico S. Donato· Source

• Recruiting

  A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

  NCT06226883· Phase 2· Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)· Source

• Active, not recruiting

  The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

  NCT06383390· Phase 3· Eli Lilly and Company· Source

• Recruiting

  Self-care Behaviors of Type 2 Diabetes Mellitus Patients

  NCT07042399· University of Milano Bicocca· Source

• Recruiting

  Post-Market Clinical Follow Up Study With Navitor Valve

  NCT06008080· Abbott Medical Devices· Source

• Recruiting

  Ischemic And Bleeding Risk Assessment After TAVR

  NCT06000943· Niguarda Hospital· Source

• Recruiting

  Predicting Cerebrovascular Adverse Events Post Cardiac Surgery

  NCT05786274· IRCCS Policlinico S. Donato· Source

• Recruiting

  Aortic Stiffness in Patients With Genetic Aortopathies

  NCT05715203· IRCCS Policlinico S. Donato· Source

• Recruiting

  Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO-EU Trial

  NCT05496998· Medtronic Cardiovascular· Source

• Active, not recruiting

  ABTECT - Maintenance

  NCT05535946· Phase 3· Abivax S.A.· Source

• Active, not recruiting

  A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity

  NCT05556512· Phase 3· Eli Lilly and Company· Source

• Recruiting

  White Matter Hyperintensities in Amnestic Mild Cognitive Impairment or Alzheimer's Disease

  NCT06179680· IRCCS Policlinico S. Donato· Source

• Active, not recruiting

  Italian Digital Primary Cardiovascular Prevention Study

  NCT05339841· Centro Cardiologico Monzino· Source

• Active, not recruiting

  Evolut™ EXPAND TAVR II Pivotal Trial

  NCT05149755· Medtronic Cardiovascular· Source

• Active, not recruiting

  A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)

  NCT05239728· Phase 3· Merck Sharp & Dohme LLC· Source

• Recruiting

  Italian Anderson Fabry Disease Cardiovascular Registry

  NCT06806813· IRCCS Azienda Ospedaliero-Universitaria di Bologna· Source

• Active, not recruiting

  Investigation of the Neurovegetative Pattern in Patients With Thoracic Aortic Aneurysms (TAA)

  NCT05703893· IRCCS Policlinico S. Donato· Source

• Active, not recruiting

  Transcriptomic Study of Adult Population With Marfan Syndrome

  NCT05700175· IRCCS Policlinico S. Donato· Source

• Active, not recruiting

  Evaluation of TAVR Using the NAVITOR Valve in a Global Investigation

  NCT04788888· Abbott Medical Devices· Source

• Recruiting

  Metabolic Exercise Test Data Combined with Cardiac and Kidney Indexes (MECKI) Score Evolution: Identification of Cardiovascular Risk in Patients with Heart Failure

  NCT06884631· Centro Cardiologico Monzino· Source

• Recruiting

  Abbott Vascular Medical Device Registry

  NCT04573660· Abbott Medical Devices· Source

• Active, not recruiting

  A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease

  NCT04232553· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  Portico Next Generation Approval Study

  NCT04011722· Abbott Medical Devices· Source

• Recruiting

  Distribution of Lymph Node Metastases in Esophageal Carcinoma

  NCT03222895· Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)· Source

• Active, not recruiting

  Evaluate the Safety and Performance of the AccuCinch® Ventricular Repair System - The CorCinch-EU Study

  NCT03183895· Ancora Heart, Inc.· Source

• Recruiting

  OUTcomes Evaluation of Current Therapeutic STrategies for Severe Aortic Valve steNosis anD the agING Population in ITALY

  NCT05778773· IRCCS Policlinico S. Donato· Source

• Active, not recruiting

  AHEAD: European Feasibility Study of the Cardiovalve Transfemoral Mitral Valve System

  NCT03339115· Cardiovalve Ltd.· Source

• Recruiting

  miRNAs in Critical Limb Ischemia (miRNACLI)

  NCT06066268· IRCCS Policlinico S. Donato· Source

• Recruiting

  Heart Failure and Aortic Stenosis Transcriptome

  NCT03268135· IRCCS Policlinico S. Donato· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Aortic stenosis8 recruiting
• Aortic aneurysm4 recruiting
• Coronary artery disease4 recruiting
• Alzheimer disease3 recruiting
• Heart failure3 recruiting
• Fabry disease2 recruiting
• Stroke2 recruiting
• Atrial fibrillation1 recruiting
• Childhood cancers1 recruiting
• Chronic spontaneous urticaria1 recruiting
• Colorectal cancer1 recruiting
• Crohn's disease1 recruiting
• Familial hypercholesterolaemia1 recruiting
• Gastric and oesophageal cancer1 recruiting
• Mild cognitive impairment1 recruiting
• Peripheral artery disease1 recruiting
• Type 2 diabetes1 recruiting
• Ulcerative colitis1 recruiting

Closed trials

• Completed

  EmploYEd Antithrombotic Therapies in Patients With Acute Coronary Syndromes HOspitalized in iTalian CCUs

  NCT06316128· Heart Care Foundation· Source

• Completed

  Thresholds of SLR Maneuver in Obese Patients

  NCT06222177· IRCCS Policlinico S. Donato· Source

• Completed

  Levels of Inflammation in People With Cardiovascular Disease (POSEIDON)

  NCT06122961· Novo Nordisk A/S· Source

• Active, not recruiting

  Study to Evaluate Safety, Tolerability and Drug Levels of BMS-986435/MYK-224 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)

  NCT06122779· Phase 2· Bristol-Myers Squibb· Source

• Completed

  A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 52 Weeks of Treatment

  NCT06088043· Phase 3· Takeda· Source

• Active, not recruiting

  A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)

  NCT06081894· Phase 3· Cytokinetics· Source

• Completed

  OptimiZation Of Lipid Lowering Therapies Using a Decision Support System In Patients With Acute Coronary Syndrome.

  NCT05844566· Imperial College London· Source

• Completed

  ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1

  NCT05507203· Phase 3· Abivax S.A.· Source

• Active, not recruiting

  A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight

  NCT05567796· Phase 3· Novo Nordisk A/S· Source

• Completed

  Biomarkers of LONG COVID (LONG COVID_LCM)

  NCT05672602· IRCCS Policlinico S. Donato· Source

• Completed

  New Patient-specific Functional Assessment of the Anomalous Aortic Origin of Coronary Arteries.

  NCT05159791· IRCCS Policlinico S. Donato· Source

• Completed

  Fractional Flow Reserve or 3D-Quantitative-Coronary-Angiography Based Vessel-FFR Guided Revascularization

  NCT04931771· ECRI bv· Source

• Completed

  Bace1as Role in Heart Failure (BACE1AS-HF)

  NCT06213493· IRCCS Policlinico S. Donato· Source

• Completed

  A Study of Pulmonary Arterial Hypertension Participants Treated With Macitentan or Selexipag

  NCT04567602· Janssen-Cilag S.p.A.· Source

• Completed

  Randomized Comparison of Abluminus DES+ Sirolimus-Eluting Stents Versus Everolimus-Eluting Stents in Coronary Artery Disease Patients With Diabetes Mellitus Global

  NCT04236609· Concept Medical Inc.· Source

• Completed

  Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)

  NCT04210115· Phase 3· Merck Sharp & Dohme LLC· Source

• Completed

  Observational Study of Patients With Moderate to Severe Chronic Plaque Psoriasis

  NCT03982394· AbbVie· Source

• Completed

  Epidemiological Description of Health Determinants in Italian Anticoagulated Population

  NCT05710562· IRCCS Policlinico S. Donato· Source

• Completed

  Non-interventional Study of Ocrelizumab in Participants With Relapsing or Primary Progressive Multiple Sclerosis

  NCT03593590· Hoffmann-La Roche· Source

• Completed

  FORWARD PRO Study Interventional Post-market Study With the Evolut™ PRO System

  NCT03417011· Medtronic Cardiovascular· Source

• Completed

  Stopping Aminosalicylate Therapy in Inactive Crohn's Disease

  NCT03261206· Phase 4· Alimentiv Inc.· Source

• Completed

  A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

  NCT01848561· AbbVie· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Congenital heart disease27 works · 0 trials
• Aortic stenosis27 works · 12 trials
• Aortic aneurysm11 works · 6 trials
• Fabry disease4 works · 2 trials
• Essential tremor4 works · 0 trials